Diseases, Conditions, Syndromes

Vaccination coverage high for children aged 19 to 35 months

(HealthDay)—Vaccination coverage has remained above 90 percent for many vaccinations among young children, and progress is being made toward immunization information systems (IISs) program goals, according to two studies ...

Diseases, Conditions, Syndromes

Which vaccinations should I get as an adult?

Before vaccines were developed, infectious diseases such as diphtheria, tetanus and meningitis were the leading cause of death and illness in the world. Vaccines are one of the greatest public health achievements in history, ...

Oncology & Cancer

Single-dose PCV13 immunogenic, safe in pediatric oncology

(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.

Diseases, Conditions, Syndromes

Study reveals new insight into susceptibility to pneumonia

A new research study of immune responses to pneumococcal vaccines, commonly given to people with compromised immune systems, young children and people over 65, has identified a type of immune cell which is important in generating ...

Pediatrics

Post-PCV13 drop in Streptococcus pneumoniae bacteremia

(HealthDay)—Introduction of seven-valent and 13-valent pneumococcal conjugate vaccine (PCV13) correlated with a reduction in Streptococcus pneumoniae bacteremia, according to a review published online March 10 in Pediatrics.

Medical research

Team uses Google analytical tool to gauge vaccine effectiveness

Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of ...

page 2 from 8